Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 12345 Next »
Viewing Page 1 of 12 | Showing Results 1 - 5 of 56

A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel on Ablation of Upper Urinary Tract Urothelial Carcinoma

The study is investigating the ability of UroGen's MitoGel? procedure to treat urothelial carcinoma tumors from the upper urinary tract. If this...

Jennifer Linehan, M.D.
  • Providence Los Angeles Research Center
  • Providence St. Johns Health Center (PSJHC)

Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)

In this study, participants with high risk non-muscle-invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette Guerin (BCG) therapy and...

Timothy Wilson, M.D.
  • Providence Los Angeles Research Center
  • Providence St. Johns Health Center (PSJHC)

A Prospective Observational Cohort Study of Patients with Castration-Resistant Prostate Cancer (CRPC) in the United States

The purpose of this study is to describe patterns of care in CRPC patients, as well as health-related quality of life (HRQoL) outcomes associated...

Timothy Wilson, M.D.
  • Providence Los Angeles Research Center
  • Providence St. Johns Health Center (PSJHC)

Phase Ib Study of Intratumoral CAVATAK(TM) (Coxsackievirus A21) and Ipilimumab in Patients with Advanced Melanoma

The study will use the established dose of CAVATAK with ipilimumab in patients with advanced melanoma for whom ipilimumab would be considered...

Steven O'Day, M.D.
  • California Research
  • Providence Los Angeles Research Center
  • Providence St. Johns Health Center (PSJHC)

A Prospective, Randomized, Blinded, Placebo-Controlled, Phase IIB Trial Of An Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine vs. Unloaded YCWP + DC in Stage III and Stage IV (Resected) Melanoma To Prevent Recurrence

The majority of melanoma vaccines tested to date have been antigen-specific vaccines targeting melanoma-specific or associated antigens and...

Steven O'Day, M.D.
  • California Research
  • Providence Los Angeles Research Center
  • Providence St. Johns Health Center (PSJHC)
« Previous 12345 Next »
Viewing Page 1 of 12 | Showing Results 1 - 5 of 56